We do not have a policy of updating or revising forward-looking statements and, except as required by law, assume no obligation to update any forward-looking statements.SVNT-GCONTACT:Swedish Orphan Biovitrum AB (Sobi)Alan RaffenspergerChief Operating Officer+46 8 697 20 90Savient Pharmaceuticals, Inc.